Miralbell (2013) [253] examined asymmetric dimethylarginine (ADMA) as a marker of endothelial dysfunction and the plasminogen activator inhibitor 1 (PAI-1) as a marker of vascular thrombosis. This evidence concerns the gene SERPINE1 and endothelial dysfunction.